N
Intellia Therapeutics, IncNTLA
Intellia Therapeutics, Inc. (NASDAQ:NTLA) is a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies. The company's in vivo programs use CRISPR to enable precise editing of disease-causing genes directly inside the human.
US StocksHealthcareSmall CapBiotechnology
NTLA の価格トレンド
Intellia Therapeutics, Inc · TradingView フルチャート
NASDAQ:NTLA